Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency (VITAPID)

This study has been completed.
Information provided by (Responsible Party):
Peter Bergman, Karolinska University Hospital Identifier:
First received: May 26, 2010
Last updated: April 4, 2012
Last verified: April 2012